Myocardial InfarctionDisease Models, AnimalMesenchymal Stem Cell TransplantationVentricular RemodelingInjectionsMyocardiumInfarctionMyocytes, CardiacNeovascularization, PhysiologicEchocardiographyStem Cell TransplantationElectrocardiographyCerebral InfarctionAngioplasty, Balloon, CoronaryThrombolytic TherapyMesenchymal Stromal CellsCoronary AngiographyTime FactorsAnterior Wall Myocardial InfarctionRats, Sprague-DawleyMyocardial ReperfusionRisk FactorsTreatment OutcomeProspective StudiesStreptokinaseCreatine KinaseCoronary Care UnitsVentricular Function, LeftFibrinolytic AgentsCoronary DiseasePrognosisAngina PectorisPlatelet Aggregation InhibitorsFollow-Up StudiesAngina, UnstablePredictive Value of TestsStentsPercutaneous Coronary InterventionMyocardial RevascularizationCoronary ThrombosisRecurrenceMyocardial IschemiaCoronary VesselsShock, CardiogenicCoronary Artery DiseaseInferior Wall Myocardial InfarctionRisk AssessmentVentricular Dysfunction, LeftHospital MortalityCoronary CirculationStroke VolumeAcute DiseaseRetrospective StudiesChest PainBiological MarkersDogsHeart FailureHeartCoronary Artery BypassProportional Hazards ModelsRegistriesIncidenceStrokeAspirinHeart VentriclesAcute Coronary SyndromeCohort StudiesTissue Plasminogen ActivatorSurvival AnalysisSwineArrhythmias, CardiacHeart Rupture, Post-InfarctionMultivariate AnalysisHospitalizationClinical Enzyme TestsCase-Control StudiesDrug-Eluting StentsCardiac CatheterizationHemorrhageTroponin TRiskDeath, Sudden, CardiacTroponin ICardiovascular AgentsGenetic TherapyAdrenergic beta-AntagonistsMyocardial Reperfusion InjuryHemodynamicsLogistic ModelsSurvival RateTiclopidineThrombosisCardiovascular DiseasesAge FactorsCardiotonic AgentsKaplan-Meier EstimateRandomized Controlled Trials as TopicChi-Square DistributionCoronary OcclusionCoronary Stenosis